NCT06158360Recruiting
An Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
A Prospective Multi-centered Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) in Patients With Thyroid Cancer
Source: ClinicalTrials.gov · Last updated 30 Mar 2026
Brief summary (registry, in English)
This observational study aimed to evaluate the safety and efficacy of postoperative management in patients with thyroid cancer who received subtotal or total thyroidectomy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 6 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 31 Dec 2029
- Lead sponsor
- Ilsan Cha hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT06158360
What you commit to
- Study type: Observational
- Planned participants: 500
- From 1 Dec 2023 to the primary completion date, 31 Dec 2029
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function
- When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out
- When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment
- Pregnant and lactating women
- Other researchers who are judged to be unsuitable for research
Who the study is looking for
- 19 years of age or older
- Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging
- Subjects who have undergone partial thyroidectomy or total resection within 1 month
- Those who have agreed to the implementation of Chinese medicine treatment
- The Eastern Cooperative Oncology Group(ECOG) performance status 0-3
- Those who understand the content of the study and agree to participate in the study
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bundang Cha Hospital Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
| Ilsan Cha Hospital Coordinator of this site? Confirm its status | Gyeonggi-do | South Korea | Recruiting |
| Gangnam Cha Hospital Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.